The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports


Telemedicine Co. Says It's Set To Thrive in Post-Pandemic World

  ()
The pandemic changed the way many people get their basic healthcare, giving a big opening to telemedicine companies like Reliq Health Technologies Inc.

US Co. To Regain All Rights to Its AGHD Diagnostic Test

Research Report
  ()
This is set to happen because the biopharma's commercialization partner recently terminated its agreement over the product, noted an H.C. Wainwright & Co. report.

Expert Expects Life Science Co. To Do Exceptionally Well

  ()
Avivagen is an early-stage life sciences company with a patented product for immune support that causes dramatic and profitable improvements in livestock. They have been increasing their sales and market penetration at a dramatic rate, and I believe them to be at an inflection point. Research coverage is expecting a 7x return.

MRI Device Maker's Earnings Come In at High End of Forecasts

Research Report
  ()
IRadimed Corp. reported Q2/22 financial results that were modestly higher than expected. ROTH Capital Partners LLC advised in a research update that based on the company's higher revenues, improved margins, and disciplined cost control measures it is maintaining its Buy rating on IRadimed and raising its price target to $42/share (up from $40).

Monkeypox Virus Test Could Yield Revenue for Its Creator

Research Report
  ()
The Utah-based diagnostics firm has multiple shots on goal with this specific molecular test and with its convenient, fast testing platform, both in development, noted an H.C. Wainwright & Co. report.

Is Reliq Health Technologies a Nutrimental 'Buy'?

Contributed Opinion
  ()
After recovering from a short "character assassination," Reliq Health Technologies may be on the up-and-up. Clive Maund examines the latest data from the company to see if it would make a good 'buy'.

Showing Results: 1 to 10 of 10

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe